HPLC for
Peptide Analysis

Reverse phase HPLC is the workhorse of peptide purity analysis. The technique separates molecules based on hydrophobicity using a C18 or C8 stationary phase and a water-to-organic solvent gradient. Peptides elute in order of increasing hydrophobicity, and the resulting chromatogram gives you a direct readout of purity—your target peptide as the main peak, with any synthetic impurities, truncation products, or degradation species resolved as separate peaks.

For synthetic peptides, RP-HPLC purity is often the single most important quality metric. A sharp, symmetric main peak with minimal shoulders or satellite peaks indicates clean synthesis. Broad or tailing peaks may signal incomplete deprotection, residual TFA salts, or conformational heterogeneity. Coupling RP-HPLC with mass spectrometry (LC-MS) lets you assign identity to each peak, turning a purity measurement into a complete impurity profile.

Size exclusion chromatography separates molecules by hydrodynamic radius. Larger species—dimers, oligomers, and higher-order aggregates—elute first, followed by the monomeric peptide. SEC answers a fundamentally different question than RP-HPLC: not "how pure is my peptide?" but "is my peptide aggregating?"

Aggregation is a common failure mode for peptides, particularly those with hydrophobic stretches or amphipathic character. Even peptides that appear pure by RP-HPLC can form non-covalent aggregates that alter bioactivity, increase immunogenicity, or compromise formulation stability. SEC provides a direct, orthogonal measurement of the monomer-to-aggregate ratio. Tracking this ratio over time or across storage conditions gives you early warning of aggregation propensity before it becomes a downstream problem.

Hydrophobic interaction chromatography separates peptides based on surface hydrophobicity under non-denaturing, high-salt conditions. Unlike RP-HPLC, which uses organic solvents that can disrupt native structure, HIC operates in aqueous buffers with a decreasing salt gradient. Peptides bind to a mildly hydrophobic resin in high-salt buffer and elute as salt concentration drops, preserving native conformation throughout the separation.

HIC is especially valuable for characterizing oxidation variants, deamidation products, and conformational isoforms that may co-elute on RP-HPLC. It also provides insight into relative surface hydrophobicity, which correlates with aggregation propensity and formulation behavior. For peptides destined for parenteral administration, HIC data helps predict whether the molecule will remain soluble and stable in the target formulation matrix.